Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Richard Franka is active.

Publication


Featured researches published by Richard Franka.


Clinical Infectious Diseases | 2013

Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium

Arun Venkatesan; Allan R. Tunkel; Karen C. Bloch; Adam S. Lauring; James J. Sejvar; Ari Bitnun; Jean Paul Stahl; A. Mailles; M. Drebot; Charles E. Rupprecht; Jonathan S. Yoder; Jennifer R. Cope; Michael R. Wilson; Richard J. Whitley; John S. Sullivan; Julia Granerod; Cheryl A. Jones; Keith Eastwood; Katherine N. Ward; David N. Durrheim; M. V. Solbrig; L. Guo-Dong; Carol A. Glaser; Heather Sheriff; David W. Brown; Eileen C. Farnon; Sharon Messenger; Beverley J. Paterson; Ariane Soldatos; Sharon L. Roy

BACKGROUND Encephalitis continues to result in substantial morbidity and mortality worldwide. Advances in diagnosis and management have been limited, in part, by a lack of consensus on case definitions, standardized diagnostic approaches, and priorities for research. METHODS In March 2012, the International Encephalitis Consortium, a committee begun in 2010 with members worldwide, held a meeting in Atlanta to discuss recent advances in encephalitis and to set priorities for future study. RESULTS We present a consensus document that proposes a standardized case definition and diagnostic guidelines for evaluation of adults and children with suspected encephalitis. In addition, areas of research priority, including host genetics and selected emerging infections, are discussed. CONCLUSIONS We anticipate that this document, representing a synthesis of our discussions and supported by literature, will serve as a practical aid to clinicians evaluating patients with suspected encephalitis and will identify key areas and approaches to advance our knowledge of encephalitis.


Journal of Clinical Microbiology | 2008

Lagos Bat Virus in Kenya

Ivan V. Kuzmin; Michael Niezgoda; Richard Franka; Bernard Agwanda; Wanda Markotter; Janet C. Beagley; Olga Yu Urazova; Robert F. Breiman; Charles E. Rupprecht

ABSTRACT During lyssavirus surveillance, 1,221 bats of at least 30 species were collected from 25 locations in Kenya. One isolate of Lagos bat virus (LBV) was obtained from a dead Eidolon helvum fruit bat. The virus was most similar phylogenetically to LBV isolates from Senegal (1985) and from France (imported from Togo or Egypt; 1999), sharing with these viruses 100% nucleoprotein identity and 99.8 to 100% glycoprotein identity. This genome conservancy across space and time suggests that LBV is well adapted to its natural host species and that populations of reservoir hosts in eastern and western Africa have sufficient interactions to share pathogens. High virus concentrations, in addition to being detected in the brain, were detected in the salivary glands and tongue and in an oral swab, suggesting that LBV is transmitted in the saliva. In other extraneural organs, the virus was generally associated with innervations and ganglia. The presence of infectious virus in the reproductive tract and in a vaginal swab implies an alternative opportunity for transmission. The isolate was pathogenic for laboratory mice by the intracerebral and intramuscular routes. Serologic screening demonstrated the presence of LBV-neutralizing antibodies in E. helvum and Rousettus aegyptiacus fruit bats. In different colonies the seroprevalence ranged from 40 to 67% and 29 to 46% for E. helvum and R. aegyptiacus, respectively. Nested reverse transcription-PCR did not reveal the presence of viral RNA in oral swabs of bats in the absence of brain infection. Several large bat roosts were identified in areas of dense human populations, raising public health concerns for the potential of lyssavirus infection.


Emerging Infectious Diseases | 2008

Enzootic rabies elimination from dogs and reemergence in wild terrestrial carnivores, United States.

Andres Velasco-Villa; Serena A. Reeder; Lillian A. Orciari; Pamela A. Yager; Richard Franka; Jesse D. Blanton; Letha Zuckero; Patrick R. Hunt; Ernest H. Oertli; Laura E. Robinson; Charles E. Rupprecht

Independent enzootics in wild terrestrial carnivores resulted from spillover events from long-term enzootics associated with dogs.


Journal of Clinical Microbiology | 2006

Molecular Diversity of Rabies Viruses Associated with Bats in Mexico and Other Countries of the Americas

Andres Velasco-Villa; Lillian A. Orciari; Víctor Juárez-Islas; Mauricio Gómez-Sierra; Irma Padilla-Medina; Ana Flisser; Valeria Souza; Amanda Castillo; Richard Franka; Maribel Escalante-Mañe; Isaias Sauri-González; Charles E. Rupprecht

ABSTRACT Bat rabies and its transmission to humans and other species in Mexico were investigated. Eighty-nine samples obtained from rabid livestock, cats, dogs, and humans in Mexico were studied by antigenic typing and partial sequence analysis. Samples were further compared with enzootic rabies associated with different species of bats in the Americas. Patterns of nucleotide variation allowed the definition of at least 20 monophyletic clusters associated with 9 or more different bat species. Several lineages associated with distinctive antigenic patterns were found in rabies viruses related to rabies in vampire bats in Mexico. Vampire bat rabies virus lineages associated with antigenic variant 3 are widely spread from Mexico to South America, suggesting these lineages as the most likely ancestors of vampire bat rabies and the ones that have been moved by vampire bat populations throughout the Americas. Rabies viruses related to Lasiurus cinereus, Histiotus montanus, and some other not yet identified species of the genus Lasiurus were found circulating in Mexico. Long-range dissemination patterns of rabies are not necessarily associated with migratory bat species, as in the case of rabies in Desmodus rotundus and Histiotus montanus. Human rabies was associated with vampire bat transmission in most cases, and in one case, rabies transmission from free-tailed bats was inferred. The occurrence of rabies spillover from bats to domestic animals was also demonstrated. Genetic typing of rabies viruses allowed us to distinguish trends of disease dissemination and to address, in a preliminary fashion, aspects of the complex evolution of rabies viruses in different host-reservoir species.


JAMA | 2013

Raccoon Rabies Virus Variant Transmission Through Solid Organ Transplantation

Neil M. Vora; Sridhar V. Basavaraju; Katherine A. Feldman; Christopher D. Paddock; Lillian A. Orciari; Steven Gitterman; Stephanie Griese; Ryan M. Wallace; Maria A. Said; Dianna M. Blau; Gennaro Selvaggi; Andres Velasco-Villa; Jana M. Ritter; Pamela A. Yager; Agnes Kresch; Mike Niezgoda; Jesse D. Blanton; Valentina Stosor; Edward M. Falta; G. Marshall Lyon; Teresa R. Zembower; Natalia Kuzmina; Prashant K. Rohatgi; Sergio Recuenco; Sherif R. Zaki; Inger K. Damon; Richard Franka; Matthew J. Kuehnert

IMPORTANCE The rabies virus causes a fatal encephalitis and can be transmitted through tissue or organ transplantation. In February 2013, a kidney recipient with no reported exposures to potentially rabid animals died from rabies 18 months after transplantation. OBJECTIVES To investigate whether organ transplantation was the source of rabies virus exposure in the kidney recipient, and to evaluate for and prevent rabies in other transplant recipients from the same donor. DESIGN Organ donor and all transplant recipient medical records were reviewed. Laboratory tests to detect rabies virus-specific binding antibodies, rabies virus neutralizing antibodies, and rabies virus antigens were conducted on available specimens, including serum, cerebrospinal fluid, and tissues from the donor and the recipients. Viral ribonucleic acid was extracted from tissues and amplified for nucleoprotein gene sequencing for phylogenetic comparisons. MAIN OUTCOMES AND MEASURES Determination of whether the donor died from undiagnosed rabies and whether other organ recipients developed rabies. RESULTS In retrospect, the donors clinical presentation (which began with vomiting and upper extremity paresthesias and progressed to fever, seizures, dysphagia, autonomic dysfunction, and brain death) was consistent with rabies. Rabies virus antigen was detected in archived autopsy brain tissue collected from the donor. The rabies viruses infecting the donor and the deceased kidney recipient were consistent with the raccoon rabies virus variant and were more than 99.9% identical across the entire N gene (1349/1350 nucleotides), thus confirming organ transplantation as the route of transmission. The 3 other organ recipients remained asymptomatic, with rabies virus neutralizing antibodies detected in their serum after completion of postexposure prophylaxis (range, 0.3-40.8 IU/mL). CONCLUSIONS AND RELEVANCE Unlike the 2 previous clusters of rabies virus transmission through solid organ transplantation, there was a long incubation period in the recipient who developed rabies, and survival of 3 other recipients without pretransplant rabies vaccination. Rabies should be considered in patients with acute progressive encephalitis of unexplained etiology, especially for potential organ donors. A standard evaluation of potential donors who meet screening criteria for infectious encephalitis should be considered, and risks and benefits for recipients of organs from these donors should be evaluated.


Emerging Infectious Diseases | 2010

Bartonella spp. in Bats, Kenya

Michael Y. Kosoy; Ying Bai; Tarah Lynch; Ivan V. Kuzmin; Michael Niezgoda; Richard Franka; Bernard Agwanda; Robert F. Breiman; Charles E. Rupprecht

We report the presence and diversity of Bartonella spp. in bats of 13 insectivorous and frugivorous species collected from various locations across Kenya. Bartonella isolates were obtained from 23 Eidolon helvum, 22 Rousettus aegyptiacus, 4 Coleura afra, 7 Triaenops persicus, 1 Hipposideros commersoni, and 49 Miniopterus spp. bats. Sequence analysis of the citrate synthase gene from the obtained isolates showed a wide assortment of Bartonella strains. Phylogenetically, isolates clustered in specific host bat species. All isolates from R. aegyptiacus, C. afra, and T. persicus bats clustered in separate monophyletic groups. In contrast, E. helvum and Miniopterus spp. bats harbored strains that clustered in several groups. Further investigation is needed to determine whether these agents are responsible for human illnesses in the region.


Vaccine | 2009

Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals

Charles E. Rupprecht; Deborah J. Briggs; Catherine M. Brown; Richard Franka; Samuel L. Katz; Harry D. Kerr; Susan M. Lett; Robin Levis; Martin I. Meltzer; William Schaffner; Paul R. Cieslak

After exposure, human rabies is preventable by prompt application of post-exposure prophylaxis. Historically, the total number of rabies vaccine doses administered during human prophylaxis has decreased, as modern biologics have improved and scientific knowledge has grown. A review of the literature on rabies virus pathogenesis, experimental animal studies, clinical trials, epidemiological surveillance, and economic analyses was conducted to determine the potential utility of reducing the current 5-dose intramuscular series of human rabies vaccine administered in the United States. Based upon the available evidence, a reduced schedule of cell-culture rabies vaccine, administered on days 0, 3, 7, and 14, given in conjunction with rabies immune globulin, was supported and recommended by the United States Advisory Committee on Immunization Practices.


Emerging Infectious Diseases | 2008

Possible Emergence of West Caucasian Bat Virus in Africa

Ivan V. Kuzmin; Michael Niezgoda; Richard Franka; Bernard Agwanda; Wanda Markotter; Janet C. Beagley; Olga Yu Urazova; Robert F. Breiman; Charles E. Rupprecht

The prevalence of neutralizing antibody against West Caucasian bat virus (WCBV) in Miniopterus bats collected in Kenya ranged from 17% to 26%. Seropositive bats were detected in 4 of 5 locations sampled across the country. These findings provide evidence that WCBV, originally isolated in Europe, may emerge in other continents.


Journal of General Virology | 2008

Experimental study of European bat lyssavirus type-2 infection in Daubenton's bats (Myotis daubentonii)

Nicholas Johnson; Ad Vos; L. Neubert; Conrad Martin Freuling; Karen L. Mansfield; Ingrid Kaipf; A. Denzinger; D. Hicks; A. Nunez; Richard Franka; Charles E. Rupprecht; Thomas Müller; Anthony R. Fooks

European bat lyssavirus type 2 (EBLV-2) can be transmitted from Daubentons bats to humans and cause rabies. EBLV-2 has been repeatedly isolated from Daubentons bats in the UK but appears to be present at a low level within the native bat population. This has prompted us to investigate the disease in its natural host under experimental conditions, to assess its virulence, dissemination and likely means of transmission between insectivorous bats. With the exception of direct intracranial inoculation, only one of seven Daubentons bats inoculated by subdermal inoculation became infected with EBLV-2. Both intramuscular and intranasal inoculation failed to infect the bats. No animal inoculated with EBLV-2 seroconverted during the study period. During infection, virus excretion in saliva (both viral RNA and live virus) was confirmed up to 3 days before the development of rabies. Disease was manifested as a gradual loss of weight prior to the development of paralysis and then death. The highest levels of virus were measured in the brain, with much lower levels of viral genomic RNA detected in the tongue, salivary glands, kidney, lung and heart. These observations are similar to those made in naturally infected Daubentons bats and this is the first documented report of isolation of EBLV-2 in bat saliva. We conclude that EBLV-2 is most likely transmitted in saliva by a shallow bite.


Journal of General Virology | 2008

Susceptibility of North American big brown bats (Eptesicus fuscus) to infection with European bat lyssavirus type 1

Richard Franka; N. Johnson; Thomas Müller; Alfred Voß; L. Neubert; Conrad Martin Freuling; Charles E. Rupprecht; Anthony R. Fooks

The aim of this study was to determine the susceptibility of insectivorous bats (using the big brown bat as a model) to infection with European bat lyssavirus type 1a (EBLV-1a), to assess the dynamics of host immune responses and to evaluate the opportunity for horizontal viral transmission within colonies. Two isolates of EBLV-1a, originating from Slovakia (EBLV-1aSK) and Germany (EBLV-1aGE), were tested. Four different routes of inoculation were used with isolate EBLV-1aSK [10(4.8) mouse intracerebral median lethal dose (MICLD(50)) in 50 mul]: intramuscular (i.m.) in the deltoid area or masseter region, per os (p.o.) and intradermal (i.d.) scratches. Isolate EBLV-1aGE (10(3.2) and 10(2.2) MICLD(50) in 20 mul) was inoculated via the intranasal (i.n.), i.m. (low- and high-dose groups, into pectoral muscles); p.o. and intracerebral (i.c.) routes. None of the bats infected by the i.n., p.o. or i.d. route with either virus isolate developed disease during the experiments (91 or 120 days, respectively). Incubation periods were 9-12 days for i.c.-inoculated bats (66 % mortality), 12-33 days for bats inoculated i.m. with the higher dose (23-50 % mortality) and 21-58 days in bats inoculated i.m. with the lower dose of virus (57 % mortality). Virus or viral RNA in bat saliva was detected occasionally, as early as 37 days before death. All i.d.-inoculated and the majority of i.m.-inoculated bats seroconverted within 7-10 days of inoculation. These observations suggest that exposure of bats to varying doses of EBLV-1 from rabid conspecifics via natural (i.d.) routes could lead to an abortive infection and serve as a natural mode of immunization resulting in the presence of virus-neutralizing antibodies in free-ranging bats.

Collaboration


Dive into the Richard Franka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lillian A. Orciari

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Michael Niezgoda

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jesse D. Blanton

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Andres Velasco-Villa

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Xianfu Wu

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Ivan V. Kuzmin

Global Alliance for Rabies Control

View shared research outputs
Top Co-Authors

Avatar

Pamela A. Yager

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Ryan M. Wallace

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

James A. Ellison

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge